Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 352 entries
View as:

A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE

Phase: N/A Priority: Normal
NCT ID: NCT00914966 Org: User:
Start: 08/31/09 End: 05/24/12 Due: 05/24/13

A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARA

Phase: N/A Priority: Normal
NCT ID: NCT05556629 Org: User:
Start: 09/01/15 End: 01/31/26 Due: 01/31/27

Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184)

Phase: N/A Priority: Normal
NCT ID: NCT01671111 Org: User:
Start: 08/14/12 End: 04/24/14 Due: 04/24/15

Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection

Phase: N/A Priority: Normal
NCT ID: NCT01259726 Org: User:
Start: 06/27/11 End: 06/11/13 Due: 06/11/14

Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential Thrombocythaemia

Phase: N/A Priority: Normal
NCT ID: NCT01214915 Org: User:
Start: 10/27/10 End: 10/24/12 Due: 10/24/13

Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT02455622 Org: User:
Start: 10/28/15 End: 07/25/25 Due: 07/25/26

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Phase: N/A Priority: Normal
NCT ID: NCT02741596 Org: User:
Start: 05/26/16 End: 10/31/19 Due: 10/31/20

An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients

Phase: N/A Priority: Normal
NCT ID: NCT01370863 Org: User:
Start: 12/02/10 End: 05/29/12 Due: 05/29/13

Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India

Phase: N/A Priority: Normal
NCT ID: NCT04429984 Org: User:
Start: 07/28/21 End: 04/22/23 Due: 04/22/24

Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

Phase: N/A Priority: Normal
NCT ID: NCT02949362 Org: User:
Start: 12/09/16 End: 07/14/20 Due: 07/14/21

Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476

Phase: N/A Priority: Normal
NCT ID: NCT00545389 Org: User:
Start: 02/10/03 End: 10/20/04 Due: 10/20/05

Effect of SSP-004184 (SPD602) on the Pharmacokinetics of Simvastatin in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01979185 Org: User:
Start: 11/18/13 End: 12/13/13 Due: 12/13/14

Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01611974 Org: User:
Start: 07/17/12 End: 12/05/14 Due: 12/05/15

A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021

Phase: N/A Priority: Normal
NCT ID: NCT01560403 Org: User:
Start: 05/21/12 End: 07/23/13 Due: 07/23/14

Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)

Phase: N/A Priority: Normal
NCT ID: NCT01034969 Org: User:
Start: 07/10/09 End: 05/31/24 Due: 05/31/25

Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)

Phase: N/A Priority: Normal
NCT ID: NCT01421498 Org: User:
Start: 08/29/11 End: 04/28/12 Due: 04/28/13

A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of Teduglutide

Phase: N/A Priority: Normal
NCT ID: NCT00820885 Org: User:
Start: 09/06/06 End: 04/23/07 Due: 04/23/08

Short Term Observational Study in DEB Patients

Phase: N/A Priority: Normal
NCT ID: NCT02178969 Org: User:
Start: 06/24/14 End: 02/23/15 Due: 02/23/16

Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia

Phase: N/A Priority: Normal
NCT ID: NCT01898884 Org: User:
Start: 08/13/13 End: 06/18/15 Due: 06/18/16

Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02045264 Org: User:
Start: 02/21/14 End: 02/27/14 Due: 02/27/15

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Phase: N/A Priority: Normal
NCT ID: NCT01005888 Org: User:
Start: 03/14/05 End: 08/22/07 Due: 08/22/08

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

Phase: N/A Priority: Normal
NCT ID: NCT00456508 Org: User:
Start: 04/01/07 End: 09/01/10 Due: 09/01/11

Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments

Phase: N/A Priority: Normal
NCT ID: NCT00567502 Org: User:
Start: 05/31/05 End: 04/30/14 Due: 04/30/15

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Phase: N/A Priority: Normal
NCT ID: NCT03922308 Org: User:
Start: 10/09/19 End: 08/05/21 Due: 08/05/22

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03259308 Org: User:
Start: 12/05/17 End: 10/06/20 Due: 10/06/21